Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) is now available.
Changmao Biochemical Engineering Co. Ltd. reported its interim results for the six months ended June 30, 2025, showing a decrease in revenue to RMB 272,278,000 from RMB 313,802,000 in the same period in 2024. The company also reported a loss attributable to shareholders of RMB 25,790,000, compared to a loss of RMB 18,786,000 in the previous year, and the directors do not recommend an interim dividend for this period.
More about Changmao Biochemical Engineering Co. Ltd. Class H
Changmao Biochemical Engineering Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China, operating in the biochemical engineering industry. The company is listed on the Hong Kong Stock Exchange under the stock code 954.
YTD Price Performance: -20.0%
Average Trading Volume: 190,846
Technical Sentiment Signal: Sell
Current Market Cap: HK$169.5M
Find detailed analytics on 0954 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money